Company / Income Tax
Bristol Myers Squibb Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$2.3B
FY2025
5-year range
$554.0M / $2.3B
FY2021-FY2025
Trend
+310.1%
vs FY2024
Sector context
#5 of 204
Health Care
What the data says
Income Tax changed +310% YoY in FY2025, a notable deviation from the 9-year average annual change of +154%.
Based on SEC 10-K filings.
$2.3B in FY2025 with a 5-year CAGR of +1.4%. Top quartile in the Health Care sector.
Increased from $1.1B to $2.3B over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +2.3%
- 5-Year CAGR
- +1.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 204This company $2.3B Sector average $118.7M
▼
+1813.6% above sector average
Key checks
Key Insights
- 5-year CAGR of +1.4%, indicating consistent growth.
- In FY2025, income tax increased 310.1% year-over-year.
- Ranks #5 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2019.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3B | +310.1% |
| FY2024 | $554.0M | -48.9% |
| FY2023 | $1.1B | -49.0% |
| FY2022 | $2.1B | +40.2% |
| FY2021 | $1.5B | -28.7% |
| FY2020 | $2.1B | -48.9% |
| FY2019 | $4.2B | +195.2% |
| FY2018 | $1.4B | -66.1% |
| FY2017 | $4.2B | +1080.7% |
| FY2016 | $352.0M | +13.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026